What is Treace Medical Concepts, Inc.'s (TMCI) StockRank?

MoatMap's StockRank for Treace Medical Concepts, Inc. (TMCI) is 41/100, with a Hold signal. This is a composite score combining Quality (36), Value (33), and Momentum (63) factor ranks across MoatMap's 20,000+ stock universe.

Does Treace Medical Concepts, Inc. have an economic moat?

Treace Medical Concepts, Inc. (TMCI) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Treace Medical Concepts, Inc. a buy, hold, or sell?

MoatMap's current signal for Treace Medical Concepts, Inc. (TMCI) is Hold, based on a StockRank of 41/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Treace Medical Concepts, Inc. in?

Treace Medical Concepts, Inc. (TMCI) operates in the Healthcare sector, specifically the Medical Devices industry (United States).

Company Deep Dive

Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.

View Deep Dive

TMCI

Hold

Treace Medical Concepts, Inc. · Healthcare · United States · $302M · Avg Vol: $2M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-72.0%

D/E

1.1x

Dividend %

—

COMPANY DESCRIPTION

Treace Medical Concepts, Inc. is a medical device company focused on advancing the standard of care for bunion surgery through its proprietary Lapiplasty 3D Bunion Correction system. The company's competitive moat is established by its unique instrumentation, extensive clinical data supporting superior patient outcomes, and a highly specialized direct sales force. It operates as a dominant niche leader in the foot and ankle orthopedic market.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	141.8M	187.1M	209.4M	212.7M	14.5%	205.3M	207.5M	221.8M	2.1%
EPS	-0.77	-0.81	-0.90	-0.93	—	-0.92	-0.85	-0.85	—
Shares	55.6M	61.7M	62.4M	63.9M	+14.8%	65.0M	—	—	—
Debt	68.6M	70.3M	69.7M	71.9M	1.6%	73.0M	—	—	—
Equity	60.5M	137.9M	112.9M	87.3M	13.0%	—	—	—	—
Op CF	-30.6M	-34.6M	-37.2M	-16.0M	—	-14.6M	—	—	—
Inv CF	-76.5M	-81.3M	35.4M	13.3M	—	—	—	—	—
Fin CF	20.8M	109.4M	0.2M	2.1M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+9.9%

SMA 50SMA 200

$4.65

RSI (14)

49.5

52W High

$7.63

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-33.6%23.2

ROE

-72.0%13.8

GP/Assets

85.6%96.8

Op. Margin

-33.0%23.5

FCF/Assets

n/mN/A

Piotroski

26.0

Int. Cover

-9.2x23.9

D/E Ratio

1.08x13.4

Current Ratio

2.90x53.2

Value

P/E (TTM)

—N/A

EV/EBITDA

-7.2x25.0

P/FCF

n/mN/A

P/B

4.5x31.5

P/S

1.5x75.2

Div Yield

—N/A

Momentum

52W High %

61%35.8

RS 6M

137%98.3

SMA 50/200

1.53x98.4

EPS Rev 4W

+5.6%83.9

EPS Rev 12W

+5.6%81.2

EPS Improve

+8%26.9

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$302M

P/E (Forward)

-5.6x

Gross Margin

79.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TMCI are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
TMCI	Treace Medical Concepts, Inc.(you)	$302M	41	Hold
AVH.AX	AVITA Medical, Inc.	$312M	47	Hold
STIM	Neuronetics, Inc.	$224M	35	Hold
SGHT	Sight Sciences, Inc.	$471M	48	Hold
NPCE	NeuroPace, Inc.	$495M	35	Sell
MASS	908 Devices Inc.	$444M	50	Hold
OFIX	Orthofix Medical Inc.	$392M	29	Sell
CERS	Cerus Corporation	$534M	34	Sell
KIDS	OrthoPediatrics Corp.	$617M	45	Hold
RXST	RxSight, Inc.	$293M	22	Sell

Peer medians: ROE -24.4% · P/E 31.0x · Gross margin 58.8%

Treace Medical Concepts, Inc. (TMCI): Stock Score Summary

Treace Medical Concepts, Inc. (TMCI) has a MoatMap StockRank of 41/100 based on Quality (36/100), Value (33/100), and Momentum (63/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$4.65
Market Cap	$302M
P/E (Forward)	-5.55
Price/Book	4.53
Return on Equity	-72.0%
Return on Invested Capital	-33.6%
Debt/Equity	1.08x
Gross Margin	79.5%
Operating Margin	-33.0%
Revenue Growth	-4.2%
Free Cash Flow	$1M

Treace Medical Concepts, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Treace Medical Concepts, Inc.’s (TMCI) StockRank?: MoatMap’s StockRank for Treace Medical Concepts, Inc. (TMCI) is 41/100, with a Hold signal. It is a composite of Quality (36), Value (33), and Momentum (63) factor ranks across MoatMap’s 20,000+ stock universe.
Does Treace Medical Concepts, Inc. have an economic moat?: Treace Medical Concepts, Inc. (TMCI) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Treace Medical Concepts, Inc. a buy, hold, or sell?: MoatMap’s current signal for Treace Medical Concepts, Inc. (TMCI) is Hold, based on a StockRank of 41/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Treace Medical Concepts, Inc. in?: Treace Medical Concepts, Inc. (TMCI) operates in the Healthcare sector, specifically the Medical Devices industry (United States).